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Abstract
Background: Mature microRNAs (miRNAs) are single-stranded RNAs that regulate post-transcriptional gene expression. In
our previous study, we have shown that versican 39UTR, a fragment of non-coding transcript, has the ability to antagonize
miR-199a-3p function thereby regulating expression of the matrix proteins versican and fibronectin, and thus resulting in
enhanced cell-cell adhesion and organ adhesion. However, the impact of this non-coding fragment on tumorigenesis is yet
to be determined.
Methods and Findings: Using computational prediction confirmed with in vitro and in vivo experiments, we report that the
expression of versican 39UTR not only antagonizes miR-199a-3p but can also lower its steady state expression. We found
that expression of versican 39UTR in a mouse breast carcinoma cell line, 4T1, decreased miR-199a-3p levels. The decrease in
miRNA activity consequently translated into differences in tumor growth. Computational analysis indicated that both miR-
199a-3p and miR-144 targeted a cell cycle regulator, Rb1. In addition, miR-144 and miR-136, which have also been shown to
interact with versican 39UTR, was found to target PTEN. Expression of Rb1 and PTEN were up-regulated synergistically in
vitro and in vivo, suggesting that the 39UTR binds and modulates miRNA activities, freeing Rb1 and PTEN mRNAs for
translation. In tumor formation assays, cells transfected with the 39UTR formed smaller tumors compared with cells
transfected with a control vector.
Conclusion: Our results demonstrated that a 39UTR fragment can be used to modulate miRNA functions. Our study also
suggests that miRNAs in the cancer cells are more susceptible to degradation, due to its interaction with a non-coding
39UTR. This non-coding component of mRNA may be used retrospectively to modulate miRNA activities.
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Introduction
Mature miRNAs are single-stranded RNAs of approximately 21
nucleotides in length. In the cytoplasm, mature miRNA and
Argonaute proteins make up the RNA-Induced Silencing
Complex (RISC) and function by complementary base-pairing
with the 39-untranslated regions (39UTR) of target mRNAs [1,2].
As a result, mRNA translation is repressed, and mRNA stability is
also endangered [3]. Using computational algorithms it was
predicted that miRNAs regulate about 30% of human genes [4],
but a recent inspection of human 39UTR has shown that more
than 60% of protein-coding genes maintain conserved target sites
for miRNA recognition [5]. The regulatory role of miRNA has
been extensively studied in various fundamental processes such as
development [6,7], differentiation [8–10], cell proliferation
[11,12], apoptosis [13,14], cell cycle [15,16], and immune
responses [17,18]. Timing of gene regulation is important in these
processes, and the 39UTR of mRNAs have been found to contain
more than one target site recognized by the same miRNA [19,20].
Proteomics studies have shown that a single miRNA impacts
translation of hundreds of mRNAs [21,22]. In these studies, most
39UTRs of these mRNAs harbor target sites that match the seed
region of the miRNA, suggesting that miRNAs with similar seed
regions may have overlapping functions. In addition, there is
evidence demonstrating that one miRNA can regulate expression
of multiple genes of related function in order to fine tune cell
activities [23]. Thus, miRNAs that target the 39UTR of a
particular mRNA may also target a set of mRNAs with similar
function. Although some studies and models have suggested simple
regulation of genes by a miRNA, there is accumulating evidence
that multiple miRNA molecules may regulate a particular gene.
Along with this hypothesis, we have previously developed a PCR
method to screen miRNAs that potentially bind to a specific
39UTR [24]. In this study, we investigated different miRNAs that
regulate the 39UTR of a gene. A fragment of versican 39UTR was
expressed in an in vitro cell model, and its effect on miRNAs levels
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13599and cell activities were examined. The role of the 39UTR other
than being a cis-element of the mRNA was thus unveiled.
Results and Discussion
Expression of versican 39UTR reduces cell proliferation
and tumor growth
An expression construct was generated to study the function of
39UTR. The conserved region of versican 39UTR (2285–3000 bp,
Genebank access number, NM_001126336.1) was cloned and
inserted in front of a CMV promoter producing the construct
VerUTR (Figure 1a). The construct was stably expressed in a
mouse breast carcinoma cell line, 4T1, and its expression was
confirmed by RT-PCR. This cell line was chosen because of its
compatibility with BALB/c mice without rejection of transplanted
cells by the host9s immune system. Injecting these cells into the
mice represents an isogenic relationship between the host and the
tumor cells, and allows the studies of molecularly modified tumor
cells. Tumor growth and metastatic invasion induced by the 4T1
cells closely mimic human breast cancer progression, and is an
established animal model for stage IV human breast carcinoma.
To examine the effect of the expression construct VerUTR on
4T1 cells, we analyzed proliferation rates of the cells. Cells
transfected with VerUTR and cells transfected with a control
vector were cultured in low serum medium. We observed reduced
proliferation in the VerUTR cells as compared with cells
transfected with an empty vector (Figure 1b). Cell cycle was
analyzed by staining cells with propidium iodide. FACS analysis
demonstrated that there were approximately twice as many
‘control’ cells in the G2/Mitosis phase than among the VerUTR
population (Figure 1c). On the other hand, more VerUTR cells
than control cells were stalled in the G1 phase where cells were not
committed to DNA synthesis.
In tumor formation experiments, VerUTR- and vector-
transfected cells were subcutaneously injected into BALB/c mice.
Two weeks following the injection, there was a noticeable
difference in tumor size (Figure 1d). Tumors generated by cells
transfected with VerUTR were consistently smaller than tumors
generated in the control group. Statistical analysis showed that the
difference in tumorigenesis was significant two weeks post-
injection. Colony formation assays also revealed similar results
(Supplementary Information, Figure S1). We reasoned that
Figure 1. Expression of versican 39UTR reduces cell proliferation and tumor growth. (a) Mouse breast carcinoma cells 4T1 was transfected
with a fragment of versican 39UTR (700 bp) or a control vector. Pooled cells were obtained. RNA was isolated from the pooled cells and the
expression of 39UTR was confirmed by RT-PCR. (b) Cell proliferation assays were performed in cells transfected with the control vector or the 39UTR in
low serum conditions (1.5% FBS) by cell counting after trypan blue staining. *, P,0.05. Error bars indicate SD (n=5). (c) Cell cycle analysis by FACS
confirmed that the vector-transfected cells had greater population of G2/M cells than the VerUTR-transfected cells. Representative data is shown.
(n=3). (d) The cells were injected subcutaneously into BALB/c mice. Tumor size was recorded weekly and tumor growth curve was obtained for a
period of four weeks. Asterisks indicate significance. *, P,0.05. Error bars indicate SEM (n=3).
doi:10.1371/journal.pone.0013599.g001
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arrested miRNA functioning, which in turn could relieve potential
targets of these miRNAs. The results also suggest that these
miRNAs are important in supporting cell proliferation and tumor
growth. Thus, these miRNAs may function together during
oncogenesis.
The tumors were dissected, fixed and then sectioned for
immunohistochemistry. Staining with Ki67, a cell proliferation
marker, showed many Ki67-positive cells in tumors formed by
vector-transfected cells, especially at the peripheral edges of
tumors where cells proliferate (Figure 2a). Nevertheless, there was
detectable staining of Ki67 in the tumors formed by the VerUTR-
transfected cells. The staining appeared to be in small patches
throughout the tumor section, and it is possible that the cells may
be expressing low levels of VerUTR in the pooled cell population.
High magnification photos displayed a greater number of Ki67-
positive cells in the control vector tumors than in the VerUTR
tumors. This indicates that the cells transfected with control vector
were proliferating at a higher rate, which resulted in faster tumor
growth.
Tumor sections were examined for expression of two negative
cell cycle regulators, PTEN and Rb1, which could affect the
Figure 2. Expression of versican 39UTR reduces Ki67 but enhances PTEN expression. (a) The tumors were sectioned and stained for Ki67
expression. The vector tumors showed higher levels of Ki67 staining (arrows). scale bars, 100 mm. (b) The tumor sections were stained for PTEN
expression. Increased PTEN expression was detected in the 39UTR tumors. scale bars, 100 mm. (c) PTEN expression was higher in the areas of live cells
(LC) adjacent to the areas of dead cells (DC), which was more evident in the versican 39UTR tumors than in the vector tumors. scale bars, 100 mm. (d)
The tumor lysates were subject to western blot analysis, probed with anti-PTEN, anti-Rb1, and anti-actin antibodies. There was significant elevation of
Rb1 and PTEN levels in the 39UTR tumors compared with the vector control.
doi:10.1371/journal.pone.0013599.g002
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PTEN antibody showed a strong elevation of PTEN expression
ubiquitously throughout the tumor sections formed by the
VerUTR-transfected cells (Figure 2b). Tumors formed by control
cells displayed little expression of PTEN in patchy regions of the
tumors. Interestingly, there were tumor cells expressing PTEN in
the core of the VerUTR tumors, an area usually packed with cell
debris and surviving cells. It is possible that impaired miRNA
function reduced cell proliferation but enhanced cell survival. In
addition, PTEN levels were higher in live cells adjacent to dead
cell areas, and this was more evident in VerUTR tumors than in
the vector tumors (Figure 2c). However, the differences in tumor
sizes could not be ruled out as the cause of this observation.
Smaller VerUTR tumors may be supplied with comparatively
more adequate and sufficient small blood vessels. Tumor sections
were also stained with Masson’s trichrome stain for collagen
visualization (SI Figure S2). The smaller VerUTR tumors were
displayed less collagen staining when compared to ‘control’
tumors, which were of significantly larger size. The difference in
abundance due to tumor size did not change the collagen
distribution.
Tumor tissues were grinded and lysed, and the expression of
PTEN and Rb1 were further examined by western blot analysis
(Figure 2d). Compared with tumors formed by the control cells,
tumors formed by the VerUTR-transfected cells exhibited
increased expression of PTEN and Rb1. The elevated expression
of these two negative cell cycle regulators could have synergisti-
cally reduced cancer cell proliferation and thus tumor growth.
Since miR-199a-3p has been shown to target versican and
fibronectin [24], tumor sections were stained with anti-versican
and anti-fibronectin antibodies. The staining showed that there
was indeed an elevation of versican and fibronectin expression in
the tumors formed by VerUTR-transfected cells. These results
suggest that the function of miR-199a-3p was likely impaired (SI
Figure S3). Transfection of VerUTR into the cells facilitated
increased translation of versican and fibronectin. It is already
known that versican isoforms V0 and V1 are expressed in the early
stages of tissue development, while the isoform V2 is expressed in
mature tissues [25,26]. We have previously demonstrated that the
V1 isoform can enhance cell proliferation, induce cell transfor-
mation, and tumor formation, while the V2 isoform can inhibit
cell proliferation and induce apoptosis [27,28]. Although it is not
known which isoform is expressed in breast cancer, our results
suggest that expression of V2 isoform may be up-regulated,
resulting in decreased cell proliferation and tumor growth.
Rb1 is targeted by miR199a-3p and miR-144
Currently, miR-199a-3p is the only miRNA that has been
shown to regulate versican expression by binding to its 39UTR.
However, versican 39UTR has been shown to interact with a
number of other miRNAs [24]. By computational algorithms, a
number of genes that are both potential targets of these miRNAs
and are negative regulators of cell cycle were obtained. A few of
these genes are of particular interest because of their targeting by
multiple versican-bound miRNAs, including Retinoblastoma1.
Rb1 is one of the well-known tumor suppressors studied and
primary cancer occurs when Rb1 protein is lost or dysfunctional
[29]. Rb1 plays the role as a negative cell cycle regulator by
postponing cells from passing G1 inter-phase [30]. Expression of
Rb1 results in reduced cell proliferation and tumor growth.
Cell lysates prepared from cells transfected with VerUTR or the
control vector were analyzed for Rb1 expression by western
blotting. Probing with anti-Rb1 antibody showed that there was an
elevated expression of Rb1 in the VerUTR cells (Figure 3a).
Primary lung and kidney tissues were collected from the VerUTR
transgenic and wildtype mice, and similar results were observed
(Figure 3b). It appears that presence of the 39UTR promoted Rb1
expression. To confirm this result, a rescue experiment was
performed by employing siRNA against the 39UTR. 4T1 cells
were transfected with the 39UTR together with siRNAs against the
39UTR or with a control sequence. As a negative control, another
set of 4T1 cells were transfected with the vector and the control
sequence. Transfected cells were then analyzed for Rb1 expres-
sion. Increased Rb1 levels were observed in the 39UTR-
transfected cells, reinforcing previous findings (Figure 3c). Trans-
fection with the addition of siRNAs successfully knocked down the
expression of Rb1 to the expression level comparable to that of the
negative control. This suggests that removal of 39UTR can readily
reduce the expression of Rb1. RNA of a duplicated set of
transfected cells was isolated and subjected to RT-PCR analysis.
No significant differences in Rb1 mRNA levels were detected.
Results of these experiments strongly related the translational
efficiency of Rb1 mRNA with the presence of 39UTR.
Two miRNAs (miR-199a-3p and miR-144) that have been
shown to interact with versican 39UTR [24] were hypothesized to
inhibit Rb1 translation (SI Figure S4a). To validate this potential
regulation, luciferase experiments were performed. The potential
binding sites of miR-199a-3p were found on Rb1 39UTR
(nucleotide 654-675, GeneBank Accession No. NM_000321.2).
The miR-199a-3p target site was highly conserved in human and
mouse genome, suggesting its importance in regulating Rb1
translation. Therefore, a region of Rb1 39UTR containing this
binding site was cloned into a luciferase reporter vector. Another
luciferase construct with mutated nucleotides located in the
miRNA-binding site was generated (Figure 3d). The presence of
a mutated binding site alleviated luciferase activity from
translational inhibition by miR-199a-3p and restored luciferase
activity by 20%. Rb1 was a potential target of miR-144, another
miRNA that binds to versican 39UTR [24]. The potential binding
site of miR-144 on Rb1 39UTR (nucleotide 674-695) was found to
be close to the miR-199a-3p target site. Moreover, this miR-144
site is highly conserved in the human and mouse genome (SI
Figure S4). Strong conservation of this region in the Rb1 39UTR
implied its importance in miRNA interaction. This region of Rb1
39UTR including the potential miR-144 binding site or its
mutated version were cloned to generate luciferase constructs.
The construct harboring the miR-144 target sequence significantly
repressed luciferase activity compared with the control vector
harboring a nonrelated fragment (Luc-Ctrl) or the mutated
construct (Figure 3e). This suggests direct targeting of Rb1 by
miR-144.
Instead of performing luciferase assays by transfecting miRNA
mimics, cells were co-transfected with a luciferase construct
harboring Rb1 39UTR and increasing concentrations of versican
39UTR (Figure 3f). As increasing quantities of 39UTR was co-
transfected with luciferase constructs, more miRNAs bound to the
39UTR and thus luciferase showed increased activity. However,
luciferase activities tended to reach plateau when 50-folds of the
39UTR were co-transfected. This suggests that translation of
endogenous Rb1 can potentially be up-regulated by 2.5-fold
without changing the transcription of the gene. Based on the results
of Rb1 targeted by miR-144 and miR-199a-3p, it is anticipated that
other miRNAs targeting Rb1 could function in the similar fashion.
In mice, miR-199a-3p has another target site located nearby the
first confirmed target site (SI Figure S5a). A known tumor
suppressor-like miRNA, miR-16, binds to versican 39UTR and
has a hypothetical target site in Rb1 mRNA. However, it does not
seem to be the determining factor in this breast cancer model.
Function of 39 UTR
PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13599Figure 3. Rb1 expression is regulated by miR-199a-3p and miR-144. (a) Cell lysate from the 39UTR- or vector-transfected cells was analyzed
on western blot for Rb1 expression. Rb1 levels were elevated in the VerUTR cells. (b) Lysates prepared from lung and kidney of VerUTR transgenic and
wildtype mice were analyzed by western blot probed with anti-Rb1 antibodies. Increased expression of Rb1 was detected in the organs from the
VerUTR transgenic mice. (c) 4T1 cells were co-transfected with VerUTR and siRNAs against 39UTR or a control sequence. The negative control was
performed by co-transfecting the cells with the vector plasmid and the control sequence. Cell lysates were prepared from transfected cells and
subject to western blot analysis probed with anti-Rb1 and anti-actin antibodies. Decreased expression was observed in the cells co-transfected with
VerUTR and siRNAs as compared with that co-transfected with VerUTR and the control sequence. (d) The Rb1 39UTR containing the potential target
site of miR-199a-3p was cloned into a luciferase vector generating a construct luc-Rb1-199a. The binding site was mutated (in red) generating luc-
Rb1-199a-mut. U343 cells were co-transfected with miR-199a-3p and the luciferase constructs. Luciferase activity assays showed that miR-199a-3p
repressed luciferase activities luc-Rb1-199a. The repression was abolished when the mi-199a-3p binding site was mutated. **, p,0.0001. Error bars,
SD (n=3). (e) A fragment of Rb1 39UTR containing the binding site for miR-144 was cloned and mutated (in red), generating luc-Rb1-144 and luc-Rb1-
144-mut, respectively. U343 cells were co-transfected with miR-144 and the luciferase constructs. Luciferase activity assays showed that mutationo f
miR-144 binding site removed the translational inhibition exerted by miR-144. **, p,0.0001. Error bars, SD (n=3). (f) Luciferase reporter vector
harboring the Rb1 39UTR was co-transfected with VerUTR construct in increasing amounts of plasmid DNA complemented with the control vector in
U343 cells. Increased abundance of VerUTR allowed translation of luciferase construct, resulting in elevation of luciferase activities.
doi:10.1371/journal.pone.0013599.g003
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Another gene of interest was Phosphotase and Tensin Homolog,
or PTEN. PTEN has been shown to function as a tumor
suppressor, where loss or mutation of this gene leads to cancer
predisposition [31]. Similar to Rb1, PTEN is also known as a
negative cell cycle regulator by arresting cells in G1 phase [32].
Increased expression of PTEN resulted in decreased cell
proliferation. To confirm these results, pooled cells transfected
with VerUTR or the control vector were lysed and probed with
anti-PTEN antibody for western blot analysis. We observed an
elevation of PTEN expression in the VerUTR-transfected cells
(Figure 4a). When primary tissues were examined for PTEN
expression, similar results were obtained but were less significant in
kidney tissues (Figure 4b). Staining of PTEN in the primary lung
tissues also yield a similar result, while expression of other proteins
were not influenced (not shown). To confirm that VerUTR could
antagonize PTEN for miRNA binding, we performed knockdown
experiments using siRNA against versican 39UTR and detected an
elevation of PTEN expression in the VerUTR-transfected cells
(Figure 4c). Knockdown of VerUTR by siRNA abolished the
increased PTEN expression to the same level seen in cells
transfected with the control vector.
Luciferase experiments were performed to validate the targeting
of PTEN by proposed miRNA candidates (SI Figure S4b). miR-
144, which potentially targets Rb1 as indicated above, was also
predicted to target PTEN. The miR-144 binding site in the
39UTR of PTEN (nucleotides 2906–2925 bp, GeneBank Acces-
sion No. NM_000314.4) was highly conserved between human
and mouse genomes and was cloned into a luciferase vector,
producing Luc-Pten-144 (SI Figure S4b). The seed sequence
matching site on the PTEN 39UTR was mutated, producing Luc-
Pten-144-mut (Figure 4d). Luciferase activity of Luc-Pten-144 was
repressed by miR-144 but could be restored when the target
sequence was mutated (Figure 4d).
By computational predictions, another versican-bound miRNA,
miR-136, could potentially target PTEN through three binding
sites on the PTEN 39UTR (nucleotides 289–311; 490–511; and
2759–2781). Two of these three sites are highly conserved in the
human and mouse genomes (SI. Figure S4b). It is possible that a
39UTR could harbor multiple sites targeted by the same miRNA,
and this has been shown by us in the study demonstrating that
CD44 39UTR is regulated by miR-328 through multiple target
sites [20]. A segment of PTEN 39UTR harboring one of the
binding sites (nucleotides 2759–2781) and its mutated version were
cloned into a luciferase vector, producing Luc-Pten-136 and Luc-
Pten-136-mut, respectively (Figure 4e). miR-136 significantly
repressed luciferase activity of Luc-Pten-136, and the repression
was almost abolished when the target sequence was mutated.
In luciferase competition assays, increasing amounts of VerUTR
were co-transfected with a luciferase construct containing PTEN
39UTR (Figure 4f). As increasing amounts of VerUTR were
transfected to antagonize endogenous miRNAs, luciferase activity
elevated respectively, signifying increasing translation of luciferase.
Although 200-folds of VerUTR were used in the transfection,
luciferase activity was 2.3-fold greater than its starting level of
activity but its maximum level was not reached. It is possible that
many miRNAs regulate PTEN or that the presence of miRNAs that
target PTEN was very abundant in the cells. As a consequence,
VerUTR could only partially regulate PTEN expression. Besides
miR-144 and miR-136, two other miRNAs, miR-16 and let-7
miRNA, could potentially interact with versican 39UTR and have
hypothetical target site on the PTEN mRNA (SI Figure S5b). The
absence of these target sites from the human genome suggests that it
is unlikely that they regulate PTEN expression.
miRNA level is affected in the presence of 39UTR
In this study, we expected to interfere with miRNA targeting by
expressing 39UTR as a decoy. We next examined how 39UTR
affected miRNA expression in vitro and in vivo. We have chosen to
focus on the expression of miR-199a-3p and miR-136 because
miR-144 is an erythroid lineage-specific miRNA [33]. The
expression of miR-199a-3p and miR-136 were detected in both
cells and several primary tissues but miR-144 was not found using
RealTime-qPCR (results not shown).
In our previous studies, miR-199a-3p was found to regulate two
extracellular matrix proteins, versican and fibronectin [24], and it
has also been shown to be important during development [34].
Expression of miR-199a-3p was analyzed in the primary lung and
kidney of VerUTR transgenic and wildtype mice. Reduction in
miRNA expression was observed in these primary tissues. There
was a 39% reduction in miR-199a-3p expression in lung tissues
but no significant changes were found between the transgenic and
wildtype kidney tissues (Figure 5a). We reasoned that different
tissues might exhibit different levels of miR-199a-3p expression,
but more importantly, different tissues might respond differently to
the presence of 39UTR. Using primary liver tissues as another
example, we detected a 29% reduction in miR-199a-3p expression
in the presence of 39UTR (Figure 5b). In addition, cells transfected
with 39UTR lost 79% of its miR-199a-3p compared with the
control cells.
Expression of miR-136 was also inspected in the primary tissues
and cells expressing VerUTR. In the primary lung tissues, there
was a 40% significant reduction in miR-136 expression, while a
significant difference between breast cancer cells transfected with
VerUTR and the control vector was not detected (Figure 5c).
Similarly, there was little difference in miR-136 levels in the kidney
of VerUTR transgenic and wildtype mice (Figure 5d). Expression
of two unrelated miRNAs, miR-17-5p and miR-328, were
examined using the same samples. No significant difference was
observed (Figure 5e).
Notably, the levels of miR-199a-3p and miR-136 were
consistently reduced in lung tissues but not kidney tissues. The
abundance of miRNA was not likely the reason for this because
miR-136 levels were similar in both lung and kidney (Figure 5d).
Clearly, other factors beyond expression levels, such as cell types,
are involved in 39UTR-mediated miRNA instability in these
tissues. A previous study suggested that imperfect miRNA
targeting is a better decoy than perfect targeting [35]. Naturally
evolved 39UTR contains imperfect binding sites for miRNAs, and
thus was expected to be able to antagonize miRNAs efficiently. In
addition, we found that antagonizing miRNA with non-coding
39UTR sequences led to miRNA instability. Human Argonaute 2
(Ago2) is part of RISC, the miRNA functional unit, and has been
shown to mediate endonucleolytic cleavage of mRNA when there
is perfect complementarity [36]. This could be a good model to
study mechanisms involved in miRNA instability. Our results
showed a general loss of miRNA abundance by 30% depending on
the types of tissues, while other miRNAs were not affected because
their targets were translated at the same efficiency (Figure 5e).
Although we only examined the abundance of two miRNAs, other
miRNAs that bind to 39UTR are likely to be affected as well.
Transient or stable transfection of 39UTR into breast cancer cells
both reduced the cellular levels of miR-199a-3p, suggesting that
the degradation process is immediate and can be prolonged.
We also observed that cancer cells tended to lose miRNA by
nearly two-fold more than primary tissues examined. It is well
accepted that genomic instability is common during cancer
progression. Due to genomic alterations, miRNA expression is
dysregulated [37], and non-coding transcripts are generated
Function of 39 UTR
PLoS ONE | www.plosone.org 6 October 2010 | Volume 5 | Issue 10 | e13599Figure 4. Targeting of PTEN by miR-144 and miR-136. (a) Cell lysates prepared from the VerUTR and control cells were analyzed on western
blot probed with anti-PTEN antibody. Increased PTEN expression was detected in the VerUTR cells, while protein loading is equal as exhibited by actin
staining. (b) Lysates prepared from lung and kidney of VerUTR transgenic and wildtype mice were probed with anti-PTEN antibody by western blot
analysis. Increased PTEN expression was observed in the organs of the VerUTR transgenic mice. (c) 4T1 cells were transiently transfected with VerUTR
and siRNAs against 39UTR or control sequence. As a negative control, 4T1 cells were also transfected with control vector and control sequence.
Lysates were prepared from transfected cells and analyzed by western blot probed with anti-PTEN and anti-actin antibodies. Decreased PTEN
expression was observed when the VerUTR was co-transfected with siRNAs against VerUTR. (d) Hypothetical targeting site by miR-144 in the 39UTR of
PTEN was cloned and mutated (in red), generating two constructs luc-PTEN-144 and luc-PTEN-144-mut. In luciferase activity assays, U343 cells were
co-transfected with luc-PTEN-144 or luc-PTEN-144-mut with miR-144. Luciferase activity of mutated construct was higher than that of the construct
expressing original 39UTR. **, p,0.001. Error bars, SD (n=3). (e) miR-136’s potential targeting sequence in the 39UTR of PTEN was cloned and
mutated (in red), generating two constructs luc-PTEN-136 and luc-PTEN-136-mut. In luciferase activity assays, U343 cells were co-transfected with luc-
PTEN-136 or luc-PTEN-136-mut with miR-136. Repression on luciferase activity was removed when miR-136 targeting site was mutated. **, p,0.001.
Error bars, SD (n=3). (f) Luciferase reporter vector harboring the PTEN 39UTR was co-transfected with VerUTR construct in increasing amounts of
plasmid DNA complemented with the control vector in U343 cells. Increased rations of VerUTR bound more endogenous miRNAs and thus freeing
the translation of luciferase protein, resulting in higher levels of luciferase activities.
doi:10.1371/journal.pone.0013599.g004
Function of 39 UTR
PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13599during this process. Binding of miRNAs to these transcripts may
have also contributed to the global reduction of miRNA levels and
functions. Currently, the mechanisms of miRNA degradation are
not as well understood as its biogenesis. An exoribonuclease found
in Arabidopsis named Small RNA Degrading enzyme 1, or SDN1,
is one of the few enzymes reported to degrade miRNA [38].
Further studies are needed to investigate the underlying mecha-
nisms of miRNA degradation.
Different approaches to regulate miRNA activity have been
tested, including decoys [39], sponges [40], locked nucleic acid
Figure 5. Expression of VerUTR affects miRNA levels. RNAs from pooled cell lines and primary tissues of the VerUTR transgenic and wild type
mice were isolated. By Real-time PCR, relative quantities of miRNAs were determined and compared with the use of miRNA-specific primers. Primary
organs from twelve mice at the age between four to six months were analyzed in these experiments. Quantitative values of miRNA levels were
normalized with U6 RNA levels for comparison. Representative data is shown. (a) In the lung tissues, the levels of miR-199a-3p were about 39% lower
in the VerUTR transgenic mice compared with that in the wildtype. In contrast, there was no significant difference between transgenic and wildtype
kidney tissues. **, p,0.01. Error bars, SD (n=3). (b) The levels of miR-199a-3p were compared between primary tissues and cancer cell lines. There is a
29% reduction in miR-199a-3p levels in the liver tissues of transgenic mice compared with that of wildtype. In the 4T1 cell line, cells transfected with
VerUTR showed 73% reduction of miR-199a-3p compared with cells transfected with the control vector. **, p,0.01. Error bars, SD (n=4). (c) Levels of
miR-136 were significantly lowered in the lung tissues of transgenic mice compared with that of wildtype by 40%. There was no significant difference
in miR-136 levels between the cells transfected with either VerUTR or the control vector. *, p,0.05. Error bars, SD (n=3). (d) Expression of miR-136 in
lung and kidney tissues of the same mice was inspected. *, p,0.05. Error bars, SD (n=3). (e) Expression of unrelated microRNAs miR-17-5p and miR-
328 were analyzed to ensure that the subjects are comparable and the levels of other miRNAs were not affected.
doi:10.1371/journal.pone.0013599.g005
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modified antisense oligonucleotides and hence usually lead to
miRNA antagonism but not miRNA degradation. Since they are
meant to antagonize specific miRNAs, they are often designed
with perfect seed region match and multiple repeats. Therefore,
they are very effective against a specific miRNA or a miRNA
family such as let-7. However, there is evidence that multiple
miRNAs can target a gene, and antagonizing one miRNA may not
relieve enough translational repression exerted by other miRNAs.
miRNA activity relies on a threshold level of expression [43], and
certain miRNAs may not be expressed abundantly in certain cell
types. In order to be able to efficiently control the translational
efficiency of a gene, knowledge of the detailed mechanisms of
miRNA regulation is required. Studies on 39UTR allow us to
experimentally validate hypothetical miRNAs that are based on its
seed region match with the conserved target sites. Assays for
validation include PCR for identification of 39UTR binding
miRNAs, real-time PCR for detection of miRNA instability, and
luciferase reporter assays for confirmation. Study of the 39UTR/
miRNA interactions will help in identification of the best potential
miRNA candidates, whereas combining multiple miRNAs will
likely result in more robust biological effects.
With the discovery of miRNAs, various cis-elements that enable
miRNA-mediated translational control are being discovered in
39UTRs. Its secondary structure formed by regions flanking target
sites determines miRNA accessibility [44]. A uridine-rich region in
the 39UTR can be bound by Dead End 1 (Dnd1), which prohibits
miRNA from associating with their target site [45]. The AU-rich
element in the 39UTR can potentially lead to translation
activation by miRNAs [46]. Our study suggests that while
39UTR enables translational regulation by miRNA, it also
regulates miRNA activity by binding to miRNAs. This means
that transcription of a gene will relieve translational suppression on
its own mRNA and others that are regulated by the same miRNA.
Because miR-199a-3p regulates translation of both versican and
fibronectin, transcription of versican will share the load of
suppression and allow increased translation of both versican and
fibronectin [24]. Therefore, results from this study suggest that
transcription of a gene may affect translation of another gene
through miRNA interactions. In terms of biological function, this
study shows that feed-forward and feedback mechanism are both
possible by versican transcription. Versican V1 and V2 isoforms
are known to exhibit opposite functions on cell proliferation [27].
When anti-proliferative versican V2 is transcribed, synergistic
action of versican V2, Rb1, and PTEN may work strongly against
proliferation. On the other hand, when proliferation-favored
versican V1 is transcribed, increased translation of Rb1 and
PTEN, if both mRNAs are present at high levels, will work against
the proliferative property of V1 but may keep its function in cell
adhesion. This mechanism can be particularly important for cell
survival where nutrients are scarce, as other miRNAs, e.g. miR-
143 [47], can interact with the 39UTR of both isoforms.
The 39UTR seems to be a mediator of miRNA function, but it
also acts as a regulator in modulating miRNA function. We found
that versican 39UTR is targeted by multiple miRNAs, which have
common targets such as Rb1 and PTEN. Expression of non-
coding 39UTR results in up-regulation of Rb1 and PTEN, which
in turn reduces cell proliferation and tumor growth. These results
are summarized in Figure 6, and depict schematically that
overexpression of versican 39UTR driven by a CMV promoter
Figure 6. Relationships of miRNA interaction with 39UTR. Computational analysis showed that miR-199a-3p, miR-144, and miR-136 potentially
targeted versican 39UTR. Overexpression of versican 39UTR would attract endogenous miR-199a-3p, miR-144, and miR-136. As a consequence, the
mRNAs of versican, Rb1, and PTEN are relieved to proceed with translation.
doi:10.1371/journal.pone.0013599.g006
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As a consequence, diminished interactions of these miRNAs with
the mRNAs of vesican, Rb1, and PTEN may occur, which in turn
may relieve these mRNAs for translation. Our study of 39UTR
reveals the existence of a RNA signaling network that has
previously been unknown. We anticipate that studies of 39UTR
will aid in identifying targets of miRNA and its application in
amplifying the effect on coding transcripts by regulating miRNA
activities.
Materials and Methods
Generation of 39UTR constructs and transgenic mice
The versican 39UTR expressing construct, VerUTR, that
transcribes conserved regions of versican 39UTR, was previously
described [24]. A luciferase reporter vector (pMir-Report;
Ambion) was used to generate the luciferase constructs. The
39UTR of Rb1 was cloned using forward primer, huRB1-SacI,
and reverse primers, huRB1-miR144MulI and huRB1-miR199-
a*MulI, by PCR. The PCR products were digested with SacI and
MluI and then inserted into a SacI and MluI-digested pMir-
Report Luciferase plasmid, to obtain luciferase constructs, Luc-
RB1-144 and Luc-RB1-199a. Primers used in this study are listed
in the SI Figure S6. Mutant constructs were generated with PCR
by the same forward primer but different reverse primers, huRB1-
miR144MulI-mut and huRB1-miR199a*MulI-mut. After double
restriction enzyme digestion by SacI and MluI, both fragments
were ligated with pMir-Report vector opened with SacI and MluI.
PTEN luciferase constructs were generated similarly. The
39UTR of PTEN was cloned by PCR using forward primer,
huPTEN-SacI, and two reverse primers, huPTEN-miR144MulI
and huRB1-miR136MulI. The PCR products were double
digested with SacI and MluI and ligated with SacI and MluI-
opened pMir-Report Luciferase plasmid, to obtain luciferase
constructs, Luc-PTEN-144 and Luc-PTEN-136. Two mutant
constructs were generated with PCR by reverse primers, huPTEN-
miR144MulI-mut and huRB1-miR36MulI-mut. After restriction
enzyme digestion by SacI and MluI, both fragments were ligated
to pMir-Report vector opened with SacI and MluI.
To serve as a negative control, a non-related sequence was
amplified from the coding sequence of the chicken versican G3
domain as previously described [23]. No miRNAs are expected to
bind to this fragment as it is in the coding region.
The VerUTR transgenic mice were generated by microinject-
ing a DNA fragment excised from versican 39UTR expressing
construct VerUTR into male pronuclei of C57BL/66CBA F2
mouse zygotes. Details of generation and genotyping methods
were previously described [24]. Tissue harvest and analysis have
been approved by the Animal Care Committee of Sunnybrook
Research Institute (Animal Use Protocol: 09-076), Ontario,
Canada.
Tumor Formation Assay and Immunohistochemistry
Six-week-old BALB/c mice received subcutaneous injections of
VerUTR- and vector-transfected 4T1 cells (5610
5 cells). Tumor
growth was monitored weekly and the sizes were recorded using a
caliper by determining the length (L) and width (W), where V=
(L6W
2)/2. Tumors were retrieved by the end of fourth week, fixed
in formalin, and sectioned. After antigen retrieval, sections were
blocked with 10% goat serum and incubated with primary
antibody against PTEN (clone 6H2.1, Millipore), or Rb1
(ab32199, ABCAM) in TBS containing 1% bovine serum albumin
(BSA) overnight. The sections were washed and labeled with
biotinylated secondary antibody, followed by avidin conjugated
horse-radish peroxidase provided by the Vectastain ABC kit
(Vector, PK-4000). DAB chromogenic reaction was performed
according to manufacturer’s protocols. The slides were subse-
quently counter-stained with Mayer’s Hematoxylin and mounted.
Cell Proliferation Assay and Cell Cycle Analysis
Cells were seeded onto 6-well plates at a density of 5610
4 cells/
well in 1.5% FBS-containing medium. Cell number was counted
by trypan blue staining daily for a period of four days. Cells were
then centrifuged at 1200 rpm for 3 minutes after initial fixation
with 70% cold ethanol and following washes by PBS. In the final
step, 1610
6 cells were resuspended in 1 ml PBS with the addition
of 100 ml ribonuclease (100 mg/ml, Sigma) and 400 ml propidium
iodide (50 mg/ml, Sigma). After leaving the samples at room
temperature for five minutes, they were acquired by a FACScan
flow cytometer (BD Biosciences), and data was analyzed using
CellQuest software.
Luciferase Activity Assay
Luciferase activity assay was performed using a dual-luciferase
reporter system developed by Promega (E1960) using the methods
described by us [48]. In short, U343 cells were seeded onto 24-well
tissue culture plates at a density of 3610
4 cells/well in 10% FBS
containing medium for 24 h. Cells were co-transfected with the
luciferase reporter constructs, corresponding miRNA mimics, and
Renilla luciferase construct by Lipofectamine 2000. The cells were
then lysed by 100 ml of passive lysis buffer per well on a shaker for
2 hours, and lysates were centrifuged for supernatant collection.
20 ml of lysates were then mixed with 100 ml of LAR II, and then
firefly luciferase activity was measured by a single-sample
luminometer. For the internal control, 100 ml of Stop & Go
reagent was added to the sample. Renilla luciferase activity was
then measured in the same tube. Luciferase activities between
different treatments were compared after normalization with
Renilla luciferase activities.
For the VerUTR competition experiments, the same luciferase
system was used. In addition to 10 mg luciferase construct
containing Rb1 or PTEN 39UTR was transfected in each well,
cells were also transfected with increasing folds of VerUTR
plasmids and corresponding amounts of control vector to a total of
2 mg plasmid per well.
Western Blot
Cells were seeded onto 6-well plates at 2610
5 cells per well
overnight. They were then transfected with 1 mg of VerUTR or
control vector in combination with scrambled RNA or siRNA
against VerUTR. Proteins were extracted 48 hours after trans-
fection by lysing in 60 ml of lysis buffer containing protease
inhibitors (150 mM NaCl, 25 mM Tris-HCl, pH 8.0, 0.5 mM
EDTA, 1% Triton X-100, 8 M Urea, and 1x protease inhibitor
cocktail). Tissues were disrupted in appropriate volume of lysis
buffer depending on tissue weight. All samples were subjected to
SDS-PAGE and then transferred to nitrocellulose membranes
followed by incubating with a rabbit monoclonal antibody against
PTEN (ab32199, ABCAM) at 1:1000 dilution, or mouse
monoclonal antibody against RB1 (ab24, ABCAM) at 1:500
dilution at 4uC overnight. The secondary antibody used was goat
anti-mouse IgG at 1:2000 dilution at room temperature for
1 hour. After detection of the protein bands, the blot was stripped
and re-probed with mouse monoclonal antibody against b-actin
(A5316, Sigma) to confirm equal loading. After secondary
antibody incubation, the blot was washed and detected by ECL
kit (Millipore) in autoradiography.
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Cells (2.5610
6) were harvested, and total RNA was extracted
with the mirVana miRNA Isolation Kit (AM1560, Ambion)
according to the manufacturer’s instructions. RT-PCR was
performed as described recently [49], while Real-time PCR assays
were performed as previously described [12,50]. Briefly, 2 mgo f
total RNA was used to synthesize cDNA by reverse transcription,
and the primers used are listed in SI Figure S6. miRNAs were
amplified by miRNA-specific primers and poly-T primer.
Comparisons between samples were made after normalization
with U6 RNA levels.
Statistical Analysis
The results (mean values 6 SD) of all the experiments were
subjected to statistical analysis by t-test. The levels of significance
were set at p,0.05.
Supporting Information
Figure S1 Colony formation affected by expression of vesicant
39UTR. In colony formation assays, pooled cell lines were mixed
in soft agarose gel and cultured in 2% FBS-containing medium.
Cells transfected with control vector formed larger but less colonies
than cells transfected with VerUTR.
Found at: doi:10.1371/journal.pone.0013599.s001 (0.14 MB
PDF)
Figure S2 Tumor sections were stained for collagen expression
by applying Trichrome to the tumor sections. Keratin and muscle
fibers were stained red, while collagen and bone are stained as blue
or green, respectively. Cytoplasm appeared as light red or pink,
and cell nuclei are dark brown to black. Within the tumor
peripheral area, there were less collagen staining in the 39UTR
tumors because of slower cell proliferation and stronger cell-cell
adhesion. In contrast, the area occupied by connective tissues was
crowded with cancer cells in the control tumor. Scale bars,
100 um.
Found at: doi:10.1371/journal.pone.0013599.s002 (0.41 MB
PDF)
Figure S3 Expression of fibronectin, versican, and CD31
affected by VUTR expression. Paraffin tumor sections were
stained with anti-vesicant (VCAN), fibronectin (FN), and CD31
antibodies. There was an increased staining of versican and
fibronectin in the tumor comprised of cells transfected with
39UTR and lots of small blood vessels were also identified. Control
tumors showed fewer but larger blood vessels spanning at the
peripheral edge. Scale bars, 100 um.
Found at: doi:10.1371/journal.pone.0013599.s003 (0.29 MB
PDF)
Figure S4 Conservation and targeting analysis. (a). The target
sequences of miR-199a-3p and miR-144 in the Rb1 39UTR are
conserved in human and mice. Conserved nucleotides are in red
and nucleotides that are complementary to miRNA are capital-
ized. (b). The binding site of miR-144 located within PTEN
39UTR are conserved between human and mice. miR-136
exhibitd more than one binding sites located in the 39UTR of
PTEN and the sequences of these target sites are very conserved.
Found at: doi:10.1371/journal.pone.0013599.s004 (0.01 MB
PDF)
Figure S5 MicroRNAs targeting Rb1 and Pten. (a). Two
additional binding sites recognized by miR-199a-3p are found in
the mouse Rb1 39UTR. miR-16, which potentially targeting
Versican 39UTR, also has a potential target site on Rb1. (b). In the
39UTR of mouse PTEN, additional sites are found to be targeted
by several Let-7 family members and miR-16, which are known
miRNAs contributing to development of cancer.
Found at: doi:10.1371/journal.pone.0013599.s005 (0.01 MB
PDF)
Figure S6 Primers used in this study.
Found at: doi:10.1371/journal.pone.0013599.s006 (0.01 MB
PDF)
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